Invitae Corporation Invitae Corporation

Invitae Corporation

NVTA

Clasificación en acciones #35786
Invitae Corporation operates as a medical genetics enterprise, striving to... Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializations such as hereditary cancer, cardiovascular health, neurological disorders, pediatric conditions, oncology, metabolic ailments, and rare diseases, alongside digital health tools and health data services. Its clientele spans individual patients, healthcare providers, biopharmaceutical firms, and other collaborators. Established in 2010 as Locus Development, Inc., the company officially became Invitae Corporation in 2012 and is headquartered in San Francisco, California.
Precio por acción
$0.016
Última sincronización: 2024-03-11
Capitalización bursátil
$3.27M
Cambio (1 día)
-5.33%
Cambio (1 año)
5,233.33%
País
US
Comercio Invitae Corporation (NVTA)

Categoría

Healthcare
Ganancias de Invitae Corporation (NVTA)
Ganancias en Sep 2023 TTM: $-1.45B
Secondo gli ultimi rapporti finanziari di Invitae Corporation, gli utili attuali della società sono $-1.45B. Nel 2022, la società ha registrato un utile di $-3.15B, una disminución en comparación con agli utili del 2021, che erano di $-415.86M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Invitae Corporation desde 2016 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
2026 (TTM) $-1.45B -100.00%
2023 0.00 -100.00%
2022 $-3.15B 657.75%
2021 $-415.86M -41.78%
2020 $-714.27M 174.28%
2019 $-260.42M 97.05%
2018 $-132.16M 5.52%
2017 $-125.24M 24.92%
2016 $-100.26M 0.00%
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
$7.61B -623.31%
US
$4.76B -427.50%
US
$-252.70M -82.62%
US
- -
CN
$1.66B -214.03%
US